CDx^® Media and Press Releases

Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent - Studies Confirm an Important Advance Against the Most Rapidly Growing Cancer in the U.S.

May 19, 2011
Read more >

Brush Biopsy Plus Forceps Biopsy Increase Detection of Barrett's Esophagus and Dysplasia, Two Studies Report

Gastroenterology & Endoscopy News, May 2011
Read more >

New Method for Detection of Precancerous Cells in Heartburn Patients Can Help to Prevent Esophageal Adenocarcinoma, the Most Rapidly Growing Form of Cancer in the U.S.

March 24, 2011
Read more >

For general corporate information and background, please visit the other on-line resources listed below.
Executive Team | CDx Technology | Clinical Studies | Video Library

If you are not a member of the media, please submit your inquiry on our Contact Us page. Every effort will be made to respond to your request in a timely manner.

CDx Diagnostics^™

CDx Diagnostics^™ is the world's leader in the detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. Our tests are primarily used to help prevent cancer before it can start by identifying still-harmless dysplasias (precancers),and are also used to identify early stage cancers when they can be most easily cured. Clinicians use CDx^® patented brush biopsy instruments to non-invasively collect a broad, full thickness tissue specimen of a suspect lesion. This unique tissue specimen is then subjected to specialized, computer-assisted laboratory analysis. These life saving tests are nationally available to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists.

CDx^® Media and Press Releases

Media Contact

CDx Diagnostics^™

Get in touch

CDx® Media and Press Releases

Media Contact

CDx Diagnostics™

Get in touch

CDx^® Media and Press Releases

CDx Diagnostics^™